Search

Your search keyword '"Macdougall, I"' showing total 355 results

Search Constraints

Start Over You searched for: Author "Macdougall, I" Remove constraint Author: "Macdougall, I"
355 results on '"Macdougall, I"'

Search Results

1. Effects of empagliflozin on progression of chronic kidney disease: a prespecified secondary analysis from the empa-kidney trial

2. Impact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trial

3. Kidney and Cardiovascular Effects of Canagliflozin According to Age and Sex: A Post Hoc Analysis of the CREDENCE Randomized Clinical Trial

5. Effect of SGLT2 Inhibitors on Stroke and Atrial Fibrillation in Diabetic Kidney Disease: Results From the CREDENCE Trial and Meta-Analysis

6. Effect of SGLT2 inhibitors on stroke and atrial fibrillation in diabetic kidney disease: Results from the CREDENCE trial and meta-analysis

7. Daprodustat for the treatment of anemia in patients not undergoing dialysis

8. The association between iron deficiency and outcomes: a secondary analysis of the intravenous iron therapy to treat iron deficiency anaemia in patients undergoing major abdominal surgery (PREVENTT) trial.

11. CKD ANAEMIA

12. CKD ANAEMIA

16. Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy

23. The Canagliflozin and Renal Endpoints in Diabetes with Established Nephropathy Clinical Evaluation (CREDENCE) Study Rationale, Design, and Baseline Characteristics

24. Canagliflozin and Cardiovascular and Renal Outcomes in Type 2 Diabetes Mellitus and Chronic Kidney Disease in Primary and Secondary Cardiovascular Prevention Groups Results From the Randomized CREDENCE Trial

25. Tolvaptan in Patients with Autosomal Dominant Polycystic Kidney Disease

26. Erythropoietic response to oral iron in patients with nondialysis-dependent chronic kidney disease in the FIND-CKD trial

29. A Pretty Ghastly, Awful Picture

35. High cardiovascular event rates occur within the first weeks of starting hemodialysis

36. DIALYSIS ANAEMIA

37. On the safety of intravenous iron, evidence trumps conjecture

38. On the safety of intravenous iron, evidence trumps conjecture

42. CKD LAB METHODS, PROGRESSION & RISK FACTORS 2

45. A novel structural framework for á1a/d-adrenoceptor selective antagonists identified using subtype selective pharmacophores

47. Anaemia in CKD 5D

49. Iron status in patients with chronic heart failure

Catalog

Books, media, physical & digital resources